Intercytex Raising £12 Million Via Stock

Intercytex – who shall henceforth be known casually as Mr. Roboto – is raising cash with an institutional stock offering. The biotech is offering 23M shares and 52 pence each to institutional investors across Europe and the UK. The money will be used “to complete a number of key value-driving steps, including the market launch of its first product Vavelta for facial rejuvenation and the completion of the Phase III trial for ICX-PRO.”